课题基金 / 基金详情

A novel gene therapy for pyruvate kinase deficiency.

A novel gene therapy for pyruvate kinase deficiency.
一种针对丙酮酸激酶缺乏症的新型基因疗法。
批准号:
20591264
负责人:
UTSUGISAWA Taiju
金额:
$3.0万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To establish effective hematopietic stem cell targeted gene therapy for pyruvate kinase (PK) deficiency, we generated a lentiviral vector based on a novel strategy. The lentiviral vector is capable of dual expression of short interfering RNA (siRNA) against mutated mRNA and siRNA resistant wild type PK mRNA, resulted in substitution of abnormal PK for the normal enzyme in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1634/stemcells.2007-0569
发表时间: 2008-02-01
期刊: STEM CELLS
影响因子: 5.2
作者: [Miyake, Koich, Utsugisawa, Taiju, Karlsson, Stefan]
通讯作者: Karlsson, Stefan